Versant Capital Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$21.1K Sell
1,072
-2,728
-72% -$62.2K ﹤0.01% 1932
2026
Q2
$97.8K Buy
3,800
+290
+8% +$6.72K 0.01% 951
2026
Q1
$72.2K Buy
3,510
+2,207
+169% +$49.7K 0.01% 1029
2025
Q4
$30.9K Buy
1,303
+564
+76% +$13.7K ﹤0.01% 1367
2025
Q3
$18.4K Hold
739
– – ﹤0.01% 1634
2025
Q2
$17K Hold
739
– – ﹤0.01% 1617
2025
Q1
$16.6K Hold
739
– – ﹤0.01% 1443
2024
Q4
$14.4K Buy
+739
New +$14.6K ﹤0.01% 1204

Other funds holding PRVA

Versant Capital Management's PRVA Position: Q3 2026 in Review

Versant Capital Management reduced its Privia Health (PRVA) stake by 72% in Q3 2026, selling an estimated $62.2K and leaving 1,072 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1932.

Versant Capital Management first reported a position in PRVA in Q4 2024 and has held it in 8 quarters since. The position peaked at $97.8K in Q2 2026. 8 funds tracked by Wall St. Rank hold PRVA as of Q3 2026.

  • Versant Capital Management held 1,072 shares of Privia Health worth $21.1K as of Q3 2026.
  • Versant Capital Management sold 2,728 Privia Health shares in Q3 2026, an estimated $62.2K.
  • Privia Health made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #1932 holding.
  • Versant Capital Management first reported a position in Privia Health in Q4 2024 and has held it in 8 quarters since.
  • Versant Capital Management's Privia Health position peaked at $97.8K in Q2 2026.
  • 8 funds tracked by Wall St. Rank held Privia Health as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.